Bioengineer Moni Datta Receives a $300K DoD Award to Design Biochemical Marker Technology

Datta in a red plaid shirt in front of a blue background

According to the American Heart Association, cardiovascular disease (CVD) remains the number one cause of death in the United States. Conditions for cardiomyopathy, a heart muscle disease leading to heart failure, are clinically silent until serious complications arise, and current diagnostic tools are unreliable, time consuming and expensive. Moni K. Datta, assistant professor of bioengineering at the University of Pittsburgh Swanson School of Engineering, received a $300,000 award from the Department of Defense to develop a quicker, simpler and more reliable diagnostic technology related to cardiomyopathy so that the signs of disease can be spotted and treated earlier.

Prashant N. Kumta, the Edward R. Weidlein Chair and Distinguished Professor of bioengineering, chemical and petroleum engineering, mechanical engineering and materials science, and professor of oral biology in the School of Dental Medicine, is co-investigator on the project with Robert L. Kormos, the Brack G. Hattler Professor of Cardiothoracic Surgery.

Read more at the Swanson School’s website.